DocGo Inc. Diluted Shares Outstanding (Weighted Average)
DocGo Inc. (DCGO) reported Diluted Shares Outstanding (Weighted Average) of 98.80 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-17
- DocGo Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 98.80M shares, a 0.13% decline year-over-year.
- DocGo Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 98.75M shares, a 2.80% decline year-over-year.
- DocGo Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 97.98M shares, a 16.47% decline year-over-year.
- DocGo Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 97.81M shares, a 7.98% decline year-over-year.
- DocGo Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 99.07M shares, a 9.46% decline from fiscal 2024.
- DocGo Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 109.42M shares, a 3.60% increase from fiscal 2023.
- DocGo Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 105.62M shares, a 2.57% increase from fiscal 2022.
- DocGo Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 102.98M shares, a 8.55% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 98.80M shares 10-Q · filed 2026-08-17 | 98.77M shares 10-Q · filed 2026-08-17 | 98.51M shares derived: average of 3 quarters · filed 2026-08-17 | 98.33M shares derived: average of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | 98.75M shares 10-Q · filed 2026-05-11 | 98.36M shares derived: average of 2 quarters · filed 2026-05-11 | 98.18M shares derived: average of 3 quarters · filed 2026-05-11 | 98.37M shares derived: average of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | 97.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 97.89M shares derived: average of 2 quarters · filed 2026-03-16 | 98.24M shares derived: average of 3 quarters · filed 2026-08-17 | 99.07M shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 97.81M shares 10-Q · filed 2025-11-10 | 98.37M shares derived: average of 2 quarters · filed 2026-08-17 | 99.43M shares 10-Q · filed 2025-11-10 | 103.91M shares derived: average of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | 98.93M shares 10-Q · filed 2026-08-17 | 100.26M shares 10-Q · filed 2026-08-17 | 105.94M shares derived: average of 3 quarters · filed 2026-08-17 | 106.03M shares derived: average of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | 101.59M shares 10-Q · filed 2026-05-11 | 109.45M shares derived: average of 2 quarters · filed 2026-05-11 | 108.40M shares derived: average of 3 quarters · filed 2026-05-11 | 107.88M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 117.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 111.80M shares derived: average of 2 quarters · filed 2026-03-16 | 109.97M shares derived: average of 3 quarters · filed 2026-03-16 | 109.42M shares 10-K · filed 2026-03-16 |
| 2024-09-30 | 106.29M shares 10-Q · filed 2025-11-10 | 106.31M shares derived: average of 2 quarters · filed 2025-11-10 | 106.80M shares 10-Q · filed 2025-11-10 | 108.38M shares derived: average of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | 106.32M shares 10-Q · filed 2025-08-07 | 107.31M shares 10-Q · filed 2025-08-07 | 109.08M shares derived: average of 3 quarters · filed 2026-03-16 | 108.06M shares derived: average of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | 108.51M shares 10-Q · filed 2025-05-08 | 110.46M shares derived: average of 2 quarters · filed 2026-03-16 | 108.64M shares derived: average of 3 quarters · filed 2026-03-16 | 107.38M shares derived: average of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | 112.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 108.71M shares derived: average of 2 quarters · filed 2026-03-16 | 107.00M shares derived: average of 3 quarters · filed 2026-03-16 | 105.62M shares 10-K · filed 2026-03-16 |
| 2023-09-30 | 104.99M shares 10-Q · filed 2024-11-07 | 104.29M shares derived: average of 2 quarters · filed 2024-11-07 | 103.35M shares 10-Q · filed 2024-11-07 | 98.89M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 103.59M shares 10-Q · filed 2024-08-07 | 103.09M shares 10-Q · filed 2024-08-07 | 96.85M shares derived: average of 3 quarters · filed 2025-02-27 | 99.49M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 102.58M shares 10-Q · filed 2024-05-08 | 93.49M shares derived: average of 2 quarters · filed 2025-02-27 | 98.13M shares derived: average of 3 quarters · filed 2025-02-27 | 102.42M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 84.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 95.90M shares derived: average of 2 quarters · filed 2025-02-27 | 102.36M shares derived: average of 3 quarters · filed 2025-02-27 | 102.98M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 107.40M shares 10-Q · filed 2023-11-06 | 111.34M shares derived: average of 2 quarters · filed 2023-11-06 | 109.17M shares 10-Q · filed 2023-11-06 | 116.67M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | 115.28M shares 10-Q · filed 2023-08-08 | 116.35M shares 10-Q · filed 2023-08-08 | 119.76M shares derived: average of 3 quarters · filed 2024-02-28 | 110.75M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | 115.65M shares 10-Q · filed 2023-05-09 | 122.00M shares derived: average of 2 quarters · filed 2024-02-28 | 109.23M shares derived: average of 3 quarters · filed 2024-02-28 | 81.95M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | 128.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 106.03M shares derived: average of 2 quarters · filed 2024-02-28 | 70.71M shares derived: average of 3 quarters · filed 2024-02-28 | 94.86M shares 10-K · filed 2024-02-28 |
| 2021-09-30 | 83.70M shares 10-Q · filed 2022-11-08 | 41.90M shares derived: average of 2 quarters · filed 2022-11-08 | 83.70M shares 10-Q · filed 2022-11-08 | |
| 2021-06-30 | 90.50K shares 10-Q · filed 2022-08-09 | 90.50K shares 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | 58.39M shares 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | 58.37M shares 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |